Kurt Harrington is the CEO & Founder of Ventoux Biosciences, where he spearheads research in immune-fibrotic diseases. With over 25 years of experience in the industry, Kurt is passionate about developing innovative solutions to improve global health. He holds an MBA in Pharmaceutical Marketing from St. Joseph’s University. Outside of work, Kurt enjoys spending time with his wife, two sons, and three dogs, travel, music, cycling, and playing guitar.More...